NCT00014352View on ClinicalTrials.gov

Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2000

Primary Completion Date

March 31, 2003

Conditions
Prostate CancerThromboembolism
Interventions
DRUG

docetaxel

DRUG

doxorubicin hydrochloride

DRUG

estramustine phosphate sodium

DRUG

ketoconazole

DRUG

warfarin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00014352 - Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter